Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2005

View Archived Issues

CDC recommends Menactra meningococcal vaccine for adolescents, college freshmen

Further monitoring required for Elidel, Protopic postmarketing adverse events

PRO-2000 studied in new NIAID-sponsored international trial

Xinlay NDA accepted for filing

NicOx selected to join EICOSANOX

Abbott and OraSure sign distribution agreement for OraQuick Advance test

Bavarian Nordic to raise capital for new programs

New phase II trial for Gabapentin ER in postherpetic neuralgia

Topline data from STRIDE-2 study in PAH

Sarissa inlicenses antisense drug from Isis

Tripep seeks approval for Thai HIV trial of alpha-HGA

Vanos receives FDA approval

Private financing at Voyager to fund Alzheimer's drug development

FDA COX-2 safety review to explore potential mechanisms of risk

New data on the effects of rosiglitazone on lipid metabolism in type 2 diabetes

Antitumor effects reported for Davanat plus 5-fluorouracil in patients with advanced solid tumors

Darbepoetin alfa improves chemotherapy-induced anemia in patients with gastrointestinal cancers

Antibacterial prodrugs of 6-beta-hydroxymethylpenicillanic acid sulfone claimed in Pfizer patent

Thrombopoietin receptor (TPOR) activators disclosed by Nissan Chemical

Genelabs Technologies presents novel antiviral agents

New 5-HT receptor modulators claimed by Suven Life Sciences

Merck Frosst claims novel inhibitors of leukotriene biosynthesis

New DPP-IV inhibitors for the treatment of NIDDM reported by Fujisawa

Tibolone reduces hot flushes and sweats in tamoxifen-treated breast cancer patients

AMN-107, a novel Bcr-Abl kinase inhibitor for the treatment of CML

Efficacy of the GABA-B receptor agonist CGP-44532 in response to nicotine

New evidence for the involvement of mGluR2/3 in primate cognitive function

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...